A Double-blind, Intra-individual Comparison, POC Trial of AC-203 in EB Patients

Clinical trial NCT03468322 · COMPLETED

Trial details

NCT number: NCT03468322
Sponsor: TWi Biotechnology, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Inherited Epidermolysis Bullosa

Start date: 2018-10-20
Primary completion: 2019-04-09
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.